Clinical Associate Professor
Education and Training
1972 – 1976: B.A., University of Pennsylvania
1976 – 1980: M.D., Mount Sinai School of Medicine
1980 – 1981: Internship, Internal Medicine, Hospital of the University of Pennsylvania
1981 – 1983: Residency, Internal Medicine, Hospital of the University of Pennsylvania
1983 – 1985: Fellow, Cardiology, Hospital of the University of Pennsylvania
1985 – 1986: Fellow, Interventional Cardiology, Hospital of the University of Pennsylvania
After receiving his undergraduate degree from the University of Pennsylvania, Dr. Zimrin went on to complete his medical degree at the Mount Sinai School of Medicine in New York. He continued his training with an internship, residency and cardiology fellowship at the University of Pennsylvania, where he subsequently completed his interventional cardiology training.
Dr. Zimrin began interventional and clinical cardiology practice in Baltimore in 1986 and assisted in the early development of the coronary intervention program at St. Joseph’s Medical Center. In 1992 he initiated the interventional cardiology program at Sinai Hospital Baltimore, where he served as director until 2005.
Dr. Zimrin joined the faculty at the University of Maryland School of Medicine in 2005 and served as Director of the Interventional Cardiology Fellowship training program and Director of the Cardiac Catheterization Laboratory at the University of Maryland Medical Center until 2012 when he was appointed as Chief of the Division of Cardiology and Director of the Cardiac Catheterization Laboratory at the new University of Maryland St Joseph Medical Center. He served in those roles until 2015 when he was appointed as Chief of the Division of Cardiovascular Medicine at the University of Maryland School of Medicine with an additional appointment as System Chief of Cardiology for the University of Maryland Medical System.
Dr. Zimrin participated in drafting Maryland State PCI and cardiac surgery regulations as a member of the Clinical Advisory Group on Cardiac Surgery and PCI Services for the Maryland Health Care Commission in 2013 and continues that work as a member of the standing Cardiac Services Advisory Group. He is a founding member of the Maryland Academic Consortium for PCI Apprpriateness and Quality. His research interests have centered on new approaches to coronary revascularization with special interest in hybrid coronary revascularization. He is Board Certified in Internal Medicine, Cardiology and Interventional Cardiology.
Interventional Cardiology, Hybrid Coronary Revascularization
Zimrin D, Reichek N, Bogin K, Aurigemma G, Douglas P, Berko B, Fung H. Antianginal Effects of Intravenous Nitroglycerin over 24-Hours. Circulation, 77:1376-1384, 1988
Zimrin D, Reyes P, Reicher B, Poston R. A Hybrid Alternative for high risk left main disease. Catheterization and Cardiovascular Interventions, 69:123-127, 2007
Zimrin D, Bonatti J, Vesely MR, Lehr EJ. Hybrid Coronary Revascularization: An overview of options for anticoagulation and platelet inhibition. Heart Surg Forum 2010;13(6):E405-8
Bonaros N, Schachner T, Lehr E, Kofler M, Wiedemann B, Zimrin D, Vesely MK, Friedrich G, Bonatti J. Five Hundred Cases of Robotic Totally Endoscopic Coronary Artery Bypass Grafting: Predictors of Success and Safety. The Annals of Thoracic Surgery 2013: 95(3):803-12 (PMID 23312792)
Bonaros N, Schachner T, Kofler M, Lehr E, Lee J, Vesely M, Zimrin D, Feuchtner G, Friedrich G, Bonatti J. Advanced hybrid closed chest revascularization: An innovative strategy for the treatment of multivessel coronary artery disease, European Journal of Cardio-Thoracic Surgery 2014:Dec.46(6):e94-102 (PMID 25256825)